Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer

Alberto Briganti, Steven Joniau, Paolo Gontero, Firas Abdollah, Niccol M. Passoni, Bertrand Tombal, Giansilvio Marchioro, Burkhard Kneitz, Jochen Walz, Detlef Frohneberg, Chris H. Bangma, Markus Graefen, Alessandro Tizzani, Bruno Frea, Robert Jeffrey Karnes, Francesco Montorsi, Hein Van Poppel, Martin Spahn

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Background: The current role of radical prostatectomy (RP) in patients with high-risk disease remains controversial. Objective: To identify which high-risk prostate cancer (PCa) patients might have favorable pathologic outcomes when surgically treated. Design, setting, and participants: We evaluated 1366 patients with high-risk PCa (ie, at least one of the following risk factors: prostate-specific antigen [PSA] >20 ng/ml, cT3, biopsy Gleason 8-10) treated with RP and pelvic lymph node dissection (PLND) at eight European centers between 1987 and 2009. A favorable pathologic outcome was defined as specimen-confined (SC) disease - namely, pT2-pT3a, node negative PCa with negative surgical margins. Intervention: All patients underwent radical retropubic prostatectomy and PLND. Measurements: Univariable and multivariable logistic regression models tested the association between predictors and SC disease. A logistic regression coefficient-based nomogram was developed and internally validated using 200 bootstrap resamples. The Kaplan-Meier method was used to depict biochemical recurrence (BCR) and cancer-specific survival (CSS) rates. Results and limitations: Overall, 505 of 1366 patients (37%) had SC disease at RP. All preoperative variables (ie, age and PSA at surgery, clinical stage, and biopsy Gleason sum) were independent predictors of SC PCa at RP (all p ≤ 0.04). Patients with SC disease had significantly higher 10-yr BCR-free survival and CSS rates than patients without SC disease at RP (66% vs 47% and 98 vs 88%, respectively; all p < 0.001). A nomogram including PSA, age, clinical stage, and biopsy Gleason sum demonstrated 72% accuracy in predicting SC PCa. This study is limited by its retrospective design and by the lack of an external validation of the nomogram. Conclusions: Roughly 40% of patients with high-risk PCa have SC disease at final pathology. These patients showed excellent long-term outcomes when surgically treated, thus representing the ideal candidates for RP as the primary treatment for PCa. Prediction of such patients is possible using a nomogram based on routinely available clinical parameters.

Original languageEnglish (US)
Pages (from-to)584-592
Number of pages9
JournalEuropean Urology
Volume61
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Prostatectomy
Prostatic Neoplasms
Nomograms
Prostate-Specific Antigen
Logistic Models
Lymph Node Excision
Biopsy
Survival Rate
Recurrence
Neoplasms
Pathology
Survival

Keywords

  • High risk
  • Nomogram
  • Prostate cancer
  • Radical prostatectomy
  • Specimen confined disease

ASJC Scopus subject areas

  • Urology

Cite this

Briganti, A., Joniau, S., Gontero, P., Abdollah, F., Passoni, N. M., Tombal, B., ... Spahn, M. (2012). Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. European Urology, 61(3), 584-592. https://doi.org/10.1016/j.eururo.2011.11.043

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. / Briganti, Alberto; Joniau, Steven; Gontero, Paolo; Abdollah, Firas; Passoni, Niccol M.; Tombal, Bertrand; Marchioro, Giansilvio; Kneitz, Burkhard; Walz, Jochen; Frohneberg, Detlef; Bangma, Chris H.; Graefen, Markus; Tizzani, Alessandro; Frea, Bruno; Karnes, Robert Jeffrey; Montorsi, Francesco; Van Poppel, Hein; Spahn, Martin.

In: European Urology, Vol. 61, No. 3, 03.2012, p. 584-592.

Research output: Contribution to journalArticle

Briganti, A, Joniau, S, Gontero, P, Abdollah, F, Passoni, NM, Tombal, B, Marchioro, G, Kneitz, B, Walz, J, Frohneberg, D, Bangma, CH, Graefen, M, Tizzani, A, Frea, B, Karnes, RJ, Montorsi, F, Van Poppel, H & Spahn, M 2012, 'Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer', European Urology, vol. 61, no. 3, pp. 584-592. https://doi.org/10.1016/j.eururo.2011.11.043
Briganti, Alberto ; Joniau, Steven ; Gontero, Paolo ; Abdollah, Firas ; Passoni, Niccol M. ; Tombal, Bertrand ; Marchioro, Giansilvio ; Kneitz, Burkhard ; Walz, Jochen ; Frohneberg, Detlef ; Bangma, Chris H. ; Graefen, Markus ; Tizzani, Alessandro ; Frea, Bruno ; Karnes, Robert Jeffrey ; Montorsi, Francesco ; Van Poppel, Hein ; Spahn, Martin. / Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. In: European Urology. 2012 ; Vol. 61, No. 3. pp. 584-592.
@article{02948f3701bf463ebc2f18d16d3716f8,
title = "Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer",
abstract = "Background: The current role of radical prostatectomy (RP) in patients with high-risk disease remains controversial. Objective: To identify which high-risk prostate cancer (PCa) patients might have favorable pathologic outcomes when surgically treated. Design, setting, and participants: We evaluated 1366 patients with high-risk PCa (ie, at least one of the following risk factors: prostate-specific antigen [PSA] >20 ng/ml, cT3, biopsy Gleason 8-10) treated with RP and pelvic lymph node dissection (PLND) at eight European centers between 1987 and 2009. A favorable pathologic outcome was defined as specimen-confined (SC) disease - namely, pT2-pT3a, node negative PCa with negative surgical margins. Intervention: All patients underwent radical retropubic prostatectomy and PLND. Measurements: Univariable and multivariable logistic regression models tested the association between predictors and SC disease. A logistic regression coefficient-based nomogram was developed and internally validated using 200 bootstrap resamples. The Kaplan-Meier method was used to depict biochemical recurrence (BCR) and cancer-specific survival (CSS) rates. Results and limitations: Overall, 505 of 1366 patients (37{\%}) had SC disease at RP. All preoperative variables (ie, age and PSA at surgery, clinical stage, and biopsy Gleason sum) were independent predictors of SC PCa at RP (all p ≤ 0.04). Patients with SC disease had significantly higher 10-yr BCR-free survival and CSS rates than patients without SC disease at RP (66{\%} vs 47{\%} and 98 vs 88{\%}, respectively; all p < 0.001). A nomogram including PSA, age, clinical stage, and biopsy Gleason sum demonstrated 72{\%} accuracy in predicting SC PCa. This study is limited by its retrospective design and by the lack of an external validation of the nomogram. Conclusions: Roughly 40{\%} of patients with high-risk PCa have SC disease at final pathology. These patients showed excellent long-term outcomes when surgically treated, thus representing the ideal candidates for RP as the primary treatment for PCa. Prediction of such patients is possible using a nomogram based on routinely available clinical parameters.",
keywords = "High risk, Nomogram, Prostate cancer, Radical prostatectomy, Specimen confined disease",
author = "Alberto Briganti and Steven Joniau and Paolo Gontero and Firas Abdollah and Passoni, {Niccol M.} and Bertrand Tombal and Giansilvio Marchioro and Burkhard Kneitz and Jochen Walz and Detlef Frohneberg and Bangma, {Chris H.} and Markus Graefen and Alessandro Tizzani and Bruno Frea and Karnes, {Robert Jeffrey} and Francesco Montorsi and {Van Poppel}, Hein and Martin Spahn",
year = "2012",
month = "3",
doi = "10.1016/j.eururo.2011.11.043",
language = "English (US)",
volume = "61",
pages = "584--592",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer

AU - Briganti, Alberto

AU - Joniau, Steven

AU - Gontero, Paolo

AU - Abdollah, Firas

AU - Passoni, Niccol M.

AU - Tombal, Bertrand

AU - Marchioro, Giansilvio

AU - Kneitz, Burkhard

AU - Walz, Jochen

AU - Frohneberg, Detlef

AU - Bangma, Chris H.

AU - Graefen, Markus

AU - Tizzani, Alessandro

AU - Frea, Bruno

AU - Karnes, Robert Jeffrey

AU - Montorsi, Francesco

AU - Van Poppel, Hein

AU - Spahn, Martin

PY - 2012/3

Y1 - 2012/3

N2 - Background: The current role of radical prostatectomy (RP) in patients with high-risk disease remains controversial. Objective: To identify which high-risk prostate cancer (PCa) patients might have favorable pathologic outcomes when surgically treated. Design, setting, and participants: We evaluated 1366 patients with high-risk PCa (ie, at least one of the following risk factors: prostate-specific antigen [PSA] >20 ng/ml, cT3, biopsy Gleason 8-10) treated with RP and pelvic lymph node dissection (PLND) at eight European centers between 1987 and 2009. A favorable pathologic outcome was defined as specimen-confined (SC) disease - namely, pT2-pT3a, node negative PCa with negative surgical margins. Intervention: All patients underwent radical retropubic prostatectomy and PLND. Measurements: Univariable and multivariable logistic regression models tested the association between predictors and SC disease. A logistic regression coefficient-based nomogram was developed and internally validated using 200 bootstrap resamples. The Kaplan-Meier method was used to depict biochemical recurrence (BCR) and cancer-specific survival (CSS) rates. Results and limitations: Overall, 505 of 1366 patients (37%) had SC disease at RP. All preoperative variables (ie, age and PSA at surgery, clinical stage, and biopsy Gleason sum) were independent predictors of SC PCa at RP (all p ≤ 0.04). Patients with SC disease had significantly higher 10-yr BCR-free survival and CSS rates than patients without SC disease at RP (66% vs 47% and 98 vs 88%, respectively; all p < 0.001). A nomogram including PSA, age, clinical stage, and biopsy Gleason sum demonstrated 72% accuracy in predicting SC PCa. This study is limited by its retrospective design and by the lack of an external validation of the nomogram. Conclusions: Roughly 40% of patients with high-risk PCa have SC disease at final pathology. These patients showed excellent long-term outcomes when surgically treated, thus representing the ideal candidates for RP as the primary treatment for PCa. Prediction of such patients is possible using a nomogram based on routinely available clinical parameters.

AB - Background: The current role of radical prostatectomy (RP) in patients with high-risk disease remains controversial. Objective: To identify which high-risk prostate cancer (PCa) patients might have favorable pathologic outcomes when surgically treated. Design, setting, and participants: We evaluated 1366 patients with high-risk PCa (ie, at least one of the following risk factors: prostate-specific antigen [PSA] >20 ng/ml, cT3, biopsy Gleason 8-10) treated with RP and pelvic lymph node dissection (PLND) at eight European centers between 1987 and 2009. A favorable pathologic outcome was defined as specimen-confined (SC) disease - namely, pT2-pT3a, node negative PCa with negative surgical margins. Intervention: All patients underwent radical retropubic prostatectomy and PLND. Measurements: Univariable and multivariable logistic regression models tested the association between predictors and SC disease. A logistic regression coefficient-based nomogram was developed and internally validated using 200 bootstrap resamples. The Kaplan-Meier method was used to depict biochemical recurrence (BCR) and cancer-specific survival (CSS) rates. Results and limitations: Overall, 505 of 1366 patients (37%) had SC disease at RP. All preoperative variables (ie, age and PSA at surgery, clinical stage, and biopsy Gleason sum) were independent predictors of SC PCa at RP (all p ≤ 0.04). Patients with SC disease had significantly higher 10-yr BCR-free survival and CSS rates than patients without SC disease at RP (66% vs 47% and 98 vs 88%, respectively; all p < 0.001). A nomogram including PSA, age, clinical stage, and biopsy Gleason sum demonstrated 72% accuracy in predicting SC PCa. This study is limited by its retrospective design and by the lack of an external validation of the nomogram. Conclusions: Roughly 40% of patients with high-risk PCa have SC disease at final pathology. These patients showed excellent long-term outcomes when surgically treated, thus representing the ideal candidates for RP as the primary treatment for PCa. Prediction of such patients is possible using a nomogram based on routinely available clinical parameters.

KW - High risk

KW - Nomogram

KW - Prostate cancer

KW - Radical prostatectomy

KW - Specimen confined disease

UR - http://www.scopus.com/inward/record.url?scp=84856377811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856377811&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2011.11.043

DO - 10.1016/j.eururo.2011.11.043

M3 - Article

C2 - 22153925

AN - SCOPUS:84856377811

VL - 61

SP - 584

EP - 592

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 3

ER -